SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001493152-21-028616
Filing Date
2021-11-15
Accepted
2021-11-15 16:16:15
Documents
68
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 form10-qa.htm   iXBRL 10-Q/A 2255007
2 ex31-1.htm EX-31.1 18288
3 ex31-2.htm EX-31.2 18375
4 ex32-1.htm EX-32.1 6305
5 ex32-2.htm EX-32.2 6176
  Complete submission text file 0001493152-21-028616.txt   9825230

Data Files

Seq Description Document Type Size
6 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mymd-20210930.xsd EX-101.SCH 65629
7 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mymd-20210930_cal.xml EX-101.CAL 51684
8 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mymd-20210930_def.xml EX-101.DEF 280446
9 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mymd-20210930_lab.xml EX-101.LAB 490013
10 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mymd-20210930_pre.xml EX-101.PRE 376342
11 EXTRACTED XBRL INSTANCE DOCUMENT form10-qa_htm.xml XML 2015923
Mailing Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205
Business Address 855 N. WOLFE STREET SUITE 623 BALTIMORE MD 21205 856-848-8698
MyMD Pharmaceuticals, Inc. (Filer) CIK: 0001321834 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36268 | Film No.: 211410861
SIC: 2835 In Vitro & In Vivo Diagnostic Substances